tiprankstipranks
Biogen (BIIB)
NASDAQ:BIIB
US Market
BIIB
Biogen
RESEARCH TOOLSreports

Biogen (BIIB) Income Statement

5,003 Followers

Biogen Income Statement

Last quarter (Q4 2025), Biogen's total revenue was $2.28B, a decrease of -7.15% from the same quarter last year. In Q4, Biogen's net income was $-48.41M. See Biogen’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 9.81B$ 9.68B$ 9.84B$ 10.17B$ 10.98B
Gross Profit
$ 6.91B$ 7.37B$ 7.30B$ 7.90B$ 8.87B
Operating Expenses
$ 5.04B$ 4.88B$ 5.20B$ 5.01B$ 6.08B
Depreciation and Amortization
$ 935.40M$ 673.20M$ 494.80M$ 518.40M$ 487.70M
EBITDA
$ 3.10B$ 3.00B$ 2.38B$ 3.54B$ 3.92B
Operating Income
$ 1.88B$ 2.49B$ 2.10B$ 2.89B$ 2.79B
Other Income/Expenses
$ -476.00M$ -584.30M$ -800.50M$ 705.30M$ -1.01B
Pretax Income
$ 1.40B$ 1.91B$ 1.30B$ 3.59B$ 1.78B
Net Income
$ 1.29B$ 1.63B$ 1.16B$ 3.05B$ 1.56B
Per Share Metrics
Basic EPS
$ 8.85$ 11.20$ 8.02$ 20.97$ 10.44
Diluted EPS
$ 8.83$ 11.19$ 7.97$ 20.87$ 10.40
Weighted Average Shares Outstanding
 146.70M 145.70M 144.70M 145.30M 149.10M
Weighted Average Shares Outstanding (Diluted)
 146.70M 145.90M 145.60M 146.00M 149.60M
Currency in USD

Biogen Earnings and Revenue History